Mole Monitor | Skin Cancer Symptom Checker
  • Mole Monitor App
  • How to Use
  • Take Better Pictures
  • FAQ
  • Blog

mole monitor
better, easier skin tracking.  Guaranteed.

Download the app
Picture Skin cancer can spread quickly. Early detection saves lives. Catch it sooner.


Revolutionary drug combination approved by FDA for the treatment of advanced melanoma

2/7/2014

Comments

 
Moffitt cancer center
The FDA have now approved a powerful combination of Mekinist and Tafinlar after completing the administration's accelerated approval program.  Both drugs are effective inhibitors of cancer activity in clinical trials.

Researchers at Moffitt's Melanoma Research Center of Excellence played a pivotal role in bringing the drug combination to patients.  Dr. Jeffrey S. Weber, the center's director, commented:

“A clinical trial in which Moffitt was the major contributor showed a 76 percent success rate for patients treated with the Mekinist and Tafinlar combination. We also found this therapy reduced the incidence and severity of some of the toxic effects patients experienced when the drugs were used alone."

The combination has widely been referred to as one of the biggest steps forward in melanoma treatment in the last 30 years.



Picture Skin cancer can spread quickly. Early detection saves lives. Catch it sooner.


Comments
    Learn more
    Mole Monitor for iPhone
    Better, easier skin tracking. Guaranteed.
    Picture
    Download

    Author

    Dr Adrian L.
    General Practitioner

    RSS Feed


    Our most popular Blogs

Mole Monitor

Mole Monitor App
About Us
Sitemap
Download Mole Monitor
Mole Monitor Guarantee
Medical Disclaimer
iTunes

Research

Blog
Links

Help

How to Use Mole Monitor
Skin Cancer Guide
Melanoma Symptoms
ABCDE Self Assessment
FAQs
Contact Us

Connect

Twitter
FaceBook
  Pro-Cal Ltd © 2017
*moleMonitor is not a diagnostic or a therapeutic device. It provides users with the tools to track and better understand their skin conditions.